Cargando…

Time-dependent association between selective serotonin reuptake inhibitors and hospitalization due to hyponatremia

BACKGROUND: Selective serotonin reuptake inhibitors (SSRIs) have a wide and increasing use for the treatment of depression and anxiety. Previous studies have indicated an increased risk of hyponatremia during the first months of treatment. We aimed to investigate the detailed time-course of SSRI-ass...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mannheimer, Buster, Falhammar, Henrik, Calissendorff, Jan, Skov, Jakob, Lindh, Jonatan D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358543/ https://www.ncbi.nlm.nih.gov/pubmed/33860708 http://dx.doi.org/10.1177/02698811211001082

Ejemplares similares

Time-dependent association between omeprazole and esomeprazole and hospitalization due to hyponatremia
por: Issa, Issa, et al.
Publicado: (2022)

Association between newly initiated thiazide diuretics and hospitalization due to hyponatremia
por: Mannheimer, Buster, et al.
Publicado: (2021)

Association between lipid-lowering agents and severe hyponatremia: a population-based case–control study
por: Skov, Jakob, et al.
Publicado: (2020)

Inverse association between glucose-lowering medications and severe hyponatremia: a Swedish population-based case-control study
por: Falhammar, Henrik, et al.
Publicado: (2019)

Sex-specific risks of death in patients hospitalized for hyponatremia: a population-based study
por: Mannheimer, Buster, et al.
Publicado: (2019)

Associations Between Antihypertensive Medications and Severe Hyponatremia: A Swedish Population–Based Case–Control Study
por: Falhammar, Henrik, et al.
Publicado: (2020)

Current and Future Burdens of Heat-Related Hyponatremia: A Nationwide Register–Based Study
por: Mannheimer, Buster, et al.
Publicado: (2022)

Reduced risk for hospitalization due to hyponatraemia in lithium treated patients: A Swedish population-based case–control study
por: Falhammar, Henrik, et al.
Publicado: (2020)

Mortality in Patients With Nonfunctional Adrenal Tumors
por: Patrova, Jekaterina, et al.
Publicado: (2023)

Limited value of long-term biochemical follow-up in patients with adrenal incidentalomas-a retrospective cohort study
por: Yeomans, Hannah, et al.
Publicado: (2015)

Tuberculosis of Adrenal Glands—A Population-based Case-control Study
por: Lindh, Jonatan D, et al.
Publicado: (2023)

A study to understand the pattern of hyponatremia in patients using selective serotonin reuptake inhibitors and serotonin dopamine antagonists
por: Tomar, Love Kumar, et al.
Publicado: (2021)

Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin–Norepinephrine Reuptake Inhibitors
por: Compagner, Chad, et al.
Publicado: (2021)

Serotonin Reuptake Inhibitor and Fluvoxamine-Induced Severe Hyponatremia in a 49-Year-Old Man
por: Gabriel, Adel
Publicado: (2009)

Clinical pharmacology of serotonin selective reuptake inhibitors /
por: Preskorn, Sheldon
Publicado: (1996)

Selective serotonin reuptake inhibitors and Alzheimer’s disease
por: Mdawar, Bernadette, et al.
Publicado: (2019)

Heart Rate Recovery and Selective Serotonin Reuptake Inhibitors
por: Cerit, Levent
Publicado: (2016)

Selective serotonin reuptake inhibitor-induced galactorrhea with hyperprolactinemia
por: Bhattacharjee, Subir, et al.
Publicado: (2021)

Confounding by Indication in Studies of Selective Serotonin Reuptake Inhibitors
por: Lee, Jimin, et al.
Publicado: (2022)

Estrogenic/antiestrogenic activity of selected selective serotonin reuptake inhibitors
por: POP, ANCA, et al.
Publicado: (2015)

Bleeding and thromboembolism due to drug-drug interactions with non-vitamin K antagonist oral anticoagulants—a Swedish, register-based cohort study in atrial fibrillation outpatients
por: Holm, Johan, et al.
Publicado: (2020)

Adherence to Guidelines for Avoiding Drug Interactions Associated with Warfarin - A Nationwide Swedish Register Study
por: Lindh, Jonatan D., et al.
Publicado: (2014)

Candidate genes for antidepressant response to selective serotonin reuptake inhibitors
por: Lotrich, Francis E, et al.
Publicado: (2005)

Bioimpedance in monitoring of effects of selective serotonin reuptake inhibitor treatment
por: Alexeev, Vasiliy Grigorievich, et al.
Publicado: (2011)

Selective Serotonin Reuptake Inhibitors in Human Pregnancy: To Treat or Not to Treat?
por: Diav-Citrin, Orna, et al.
Publicado: (2012)

Behavioral destabilization induced by the selective serotonin reuptake inhibitor fluoxetine
por: Kobayashi, Katsunori, et al.
Publicado: (2011)

Enhanced Responsiveness to Selective Serotonin Reuptake Inhibitors during Lactation
por: Jury, Nicholas J., et al.
Publicado: (2015)

Selective Serotonin–norepinephrine Reuptake Inhibitors-induced Takotsubo Cardiomyopathy
por: Vasudev, Rahul, et al.
Publicado: (2016)

Ankle edema after administration of selective serotonin reuptake inhibitors
por: Kontoangelos, Konstantinos, et al.
Publicado: (2018)

Pediatric Therapeutic Drug Monitoring for Selective Serotonin Reuptake Inhibitors
por: Strawn, Jeffrey R., et al.
Publicado: (2021)

Selective Serotonin Reuptake Inhibitor Pharmaco-Omics: Mechanisms and Prediction
por: Nguyen, Thanh Thanh L., et al.
Publicado: (2021)

Off-label Uses of Selective Serotonin Reuptake Inhibitors (SSRIs)
por: Jannini, Tommaso B., et al.
Publicado: (2022)

Transient Serotonin Syndrome Caused by Concurrent Use of Tramadol and Selective Serotonin Reuptake Inhibitor
por: Shakoor, Muhammad Tariq, et al.
Publicado: (2014)

Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis
por: Gosmann, Natan Pereira, et al.
Publicado: (2021)

The Efficacy and Safety of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in the Treatment of Menopausal Hot Flashes: A Systematic Review of Clinical Trials
por: Azizi, Marzieh, et al.
Publicado: (2022)

Clinical Utility of Semistructured Interview and Scales to Assess Withdrawal Syndromes With Dose Reduction or Discontinuation of Selective Serotonin Reuptake Inhibitors or Serotonin Norepinephrine Reuptake Inhibitors
por: Cosci, Fiammetta, et al.
Publicado: (2022)

Oral selective serotonin reuptake inhibitors activate vagus nerve dependent gut-brain signalling
por: McVey Neufeld, Karen-Anne, et al.
Publicado: (2019)

RAVE DRUG (ECSTASY) AND SELECTIVE SEROTONIN REUPTAKE INHIBITOR ANTI-DEPRESSANTS
por: Singh, A.N., et al.
Publicado: (2000)

The Necessity of Bone Densitometry for Patients Taking Selective Serotonin Reuptake Inhibitors
por: An, Ki-Yong, et al.
Publicado: (2013)

Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants, Prolactin and Breast Cancer
por: Ashbury, Janet E., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_p36ngge235u92olslle85hqch8